2Theodorou SJ, Theodorou DJ, Kakitsnbata Y. Sonography and venography of the lower extremities for diagnosing deep vein thrombosis: prospective cohort study. BMJ, 1998,317 : 1037-1040.
3Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis. Blood ,2002,99:3102-3110.
5Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes P - selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res,2004,78:892-897.
二级参考文献11
1[1]McRae SJ.Eikelboom JW.Latest medical treatment strategies for venous thromboembolism.Expert Opin Pharmacother.2007;8(9):1221-33
2[2]Ernst CB,Stanley Jc.Current therapy in vascular surgery.3rd ed.USA:Mosby-Year Book,Inc,1995,888:936
3[4]Chong BH,Brishton TA,Baker RI,etc.Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis,J Thromb Thrombolysis.2005,19(3):173-81
4[5]van Dongen CJ,MacGillavry MR,Prins MH.Once versus twice daily LMWH for the initial treatment of venous thromboembolism.Once versus twice daily LMWH for the initial treatment of venous thromboembolism.Cochrane Database Syst Rev.2005,20(3):CD003074
5[6]Hyers TM.Heparin and other rapidly acting anticoagulants.Semin Vasc Surg,2005,18(3):130-3
6BellWR,StarksenNF,TongS ,etal.Trousseau’’ssyndrome:devastatingcoagulopathyintheabsenceofheparin[].The American Journal of The Medical Sciences.1985
7Harris EJJ,Kinney EV,Harris EJS,et al.Phlegmasia complicating prophylactic percutaneous inferior vena caval interruption: a word of caution[].Journal of Vascular Surgery.1995
8Levine M,Raskob GE,Landefeld CS,et al.Hemorrhagic complications of anticoagulant treatment[].Chest.1998
9Greenfield LJ,Proctor MC.Twenty-year clinical experience with the Greenfield filter[].Cardiovascular Surgery.1995
10Proctor MC.Indications for filter placement[].Seminars in Vascular Surgery.2000
